PIPages
Labs

E. Ashley Moseman

Duke University, NC·Microbiology & Immunology

Antibodies are a main defense against infection. But they cannot easily reach every tissue, and on their own they cannot always kill a pathogen.

Fields

Microbiology & Immunology

Neuroscience

Medicine & Clinical Research

Topics

immunology

antibodies

plasma cells

Grants
2 known grants, through Oct 2029

What they work on

  1. Determine when antibody-producing plasma cells settle in the olfactory mucosa (the smell-sensing lining of the nose), and how long and where in that tissue they persist after airway infection or vaccination.
  2. Define how olfactory plasma cells relate to the long-lived plasma cell pool in bone marrow, to understand why vaccines that raise blood antibody levels often fail to protect the nose.
  3. Test how isotype variants of a monoclonal antibody against Naegleria fowleri surface molecules, by engaging different Fc receptors on immune cells, direct the killing of parasites in the brain.
  4. Define how combining the antibody's parasite growth-blocking effect with isotype-specific immune attack can clear brain-eating amoeba infection while limiting damage to the brain.

More about the research

This lab studies how antibodies protect two hard-to-reach places, the nose's smell-sensing lining and the brain, and how that protection could be improved through vaccines or antibody therapies.

Why it matters

Learning how antibody-producing cells take up residence in the nasal smell-sensing lining could guide vaccines that better block upper respiratory viruses, such as SARS-CoV-2, that infect the nose and can travel toward the brain. For the nearly always fatal brain infection caused by Naegleria fowleri, the antibody work could point to immune-based treatments for patients who now have few effective options.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Defining mucosal plasma cell origin, residence, and longevity in the upper airway

NIH · Nov 2024 – Oct 2029

Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector Functions

NIH · Apr 2021 – Jan 2027

Closest labs

Geoffrey Hart

University of Minnesota, MN·Microbiology & Immunology

Test whether human NK cells, immune cells that kill antibody-coated targets, clear blood-stage Plasmodium in vivo by transferring them with human anti-merozoite antibodies into immunodeficient mice.

Xiaoyang Hua

University of Texas Health Science Center at Houston, TX·Microbiology & Immunology

Define the immune mechanisms by which a virus infecting only the nose recruits antigen-presenting cells to the lungs and boosts innate and adaptive lung immunity, a process called nose-lung cross talk.

Weina Sun

Icahn School of Medicine at Mount Sinai, NY·Microbiology & Immunology

Map when and where antigen-specific IgA- and IgG-secreting B cells arise in mucosa-associated lymphoid tissues of mice after intramuscular mRNA-LNP vaccination and after intranasal Newcastle disease virus (NDV) vaccination encoding Beta-variant spike.

The school

Duke University: 61 labs on PI Pages, $1.6B a year on research, 417 research doctorates a year.

More about Duke University

Reach out

A start for your email. Fill in the brackets.